The US Food and Drug Administration (FDA) has granted approval for Abbott’s Volt PFA System, expanding treatment options for patients with atrial fibrillation (AFib). The approval follows earlier CE ...
The FDA approved Abbott's Volt PFA System for atrial fibrillation, supported by VOLT-AF trial data showing strong safety and ...
Abstract: Accurate classification of atrial arrhythmias from single-lead ECG recordings presents significant clinical challenges, particularly for atrial flutter (AFL) subtypes characterized by ...